Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity

Arvin George, Eric Giesler, Brian Mazzarella, Richard Levin, Daniel Frendl, Christopher Warlick, Robert Given, Naveen Kella, Thomas Frye, Lance Mynderse, Ali Kasraeian, Aaron Milbank, Phillippe Nabbout, Ivan Grunberger, Ardeshir Rastinehad, Michael Schwartz, James Wysock, Michael Rousseau, Marc Pliskin, Raj Satkunasivam, David Rich, Neal D. Shore, Jose Moreno, Laurence Belkoff, Abhinav Sidana, Samir S. Taneja

Open source

DOI
10.1097/ju.0000000000005156
Published
2026-10
Container
Journal of Urology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ju.0000000000005156,
  title = {Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity},
  author = {Arvin George and Eric Giesler and Brian Mazzarella and Richard Levin and Daniel Frendl and Christopher Warlick and Robert Given and Naveen Kella and Thomas Frye and Lance Mynderse and Ali Kasraeian and Aaron Milbank and Phillippe Nabbout and Ivan Grunberger and Ardeshir Rastinehad and Michael Schwartz and James Wysock and Michael Rousseau and Marc Pliskin and Raj Satkunasivam and David Rich and Neal D. Shore and Jose Moreno and Laurence Belkoff and Abhinav Sidana and Samir S. Taneja},
  year = {2026},
  journal = {Journal of Urology},
  doi = {10.1097/ju.0000000000005156},
  url = {https://doi.org/10.1097/ju.0000000000005156}
}

RIS

TY  - JOUR
TI  - Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity
AU  - Arvin George
AU  - Eric Giesler
AU  - Brian Mazzarella
AU  - Richard Levin
AU  - Daniel Frendl
AU  - Christopher Warlick
AU  - Robert Given
AU  - Naveen Kella
AU  - Thomas Frye
AU  - Lance Mynderse
AU  - Ali Kasraeian
AU  - Aaron Milbank
AU  - Phillippe Nabbout
AU  - Ivan Grunberger
AU  - Ardeshir Rastinehad
AU  - Michael Schwartz
AU  - James Wysock
AU  - Michael Rousseau
AU  - Marc Pliskin
AU  - Raj Satkunasivam
AU  - David Rich
AU  - Neal D. Shore
AU  - Jose Moreno
AU  - Laurence Belkoff
AU  - Abhinav Sidana
AU  - Samir S. Taneja
PY  - 2026
JO  - Journal of Urology
DO  - 10.1097/ju.0000000000005156
UR  - https://doi.org/10.1097/ju.0000000000005156
ER  - 

APA

George, A., Giesler, E., Mazzarella, B., Levin, R., Frendl, D., Warlick, C., Given, R., Kella, N., Frye, T., Mynderse, L., Kasraeian, A., Milbank, A., Nabbout, P., Grunberger, I., Rastinehad, A., Schwartz, M., Wysock, J., Rousseau, M., Pliskin, M., Satkunasivam, R., Rich, D., Shore, N. D., Moreno, J., Belkoff, L., Sidana, A., & Taneja, S. S. (2026). Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity. Journal of Urology. https://doi.org/10.1097/ju.0000000000005156

Source records